Bradley McGregor, MD, contextualizes recent data on emerging treatment regimens in high-risk, BCG-naïve NMIBC.
Bradley McGregor, MD
Advertisement
Articles by Bradley McGregor, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves flibanserin for hypoactive sexual desire disorder in postmenopausal women
2
FDA grants 510(k) clearance to enhanced Revi System for urgency urinary incontinence
3
First Assist: Advancing Radiation Strategies in High-Risk and Advanced Prostate Cancer, with Pretesh Patel, MD
4
Published data support efficacy of Anktiva plus BCG in papillary-only NMIBC
5
